Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?

Breast Cancer Research and Treatment

Volumn 114, Issue 2, 2009, Pages 387-389

  Stambolic, Vuk ^a   Woodgett, James R ^b   Fantus, I George ^b,c   Pritchard, Kathleen I ^d   Goodwin, Pamela J ^b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CHEMOTHERAPY; DRUG MECHANISM; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; TUMOR VASCULARIZATION;

BREAST NEOPLASMS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; NEOVASCULARIZATION, PATHOLOGIC; RISK FACTORS;

EID: 59449091120     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0015-4     Document Type: Letter

References (16)

1. Phoenix KN, Vumbaca F, Claffey KP (2008) Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model. Breast Cancer Res Treat Feb 7 [Epub ahead of print]
2. Goodwin PJ, Pritchard KI, Fantus IG, Ennis M, Clemons M, Graham M (2006) Metformin lowers fasting insulin levels in hyperinsulinemic early stage breast cancer patients-results of a Phase II study. Breast Cancer Res Treat 100(suppl):A2085
3. PJ Goodwin M Ennis KI Pritchard ME Trudeau J Koo Y Madarnas W Hartwick B Hoffman N Hood 2002 Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study J Clin Oncol 20 1 42 51
4. P Pasanisi F Berrino M De Petris E Venturelli A Mastroianni S Panico 2006 Metabolic syndrome as a prognostic factor for breast cancer recurrences Int J Cancer 119 1 236 238
5. MN Pollak JW Chapman L Shepherd D Meng P Richardson C Wilson B Orme KI Pritchard 2006 Insulin resistance, estimated by serum C-peptide level, is associated with reduced event-free survival for postmenopausal women in NCIC CTG MA.14 adjuvant breast cancer trial J Clin Oncol 24 18S 524
6. AM Mulligan FP O'Malley M Ennis IG Fantus PJ Goodwin 2007 Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer Breast Cancer Res Treat 106 1 39 47
7. G Zhou R Myers Y Li Y Chen X Shen J Fenyk-Melody M Wu J Ventre T Doebber N Fujii N Musi MF Hirshman LJ Goodyear DE Moller 2001 Role of AMP-activated protein kinase in mechanism of metformin action J Clin Invest 108 8 1167 1174
8. RJ Shaw KA Lamia D Vasquez SH Koo N Bardeesy RA Depinho M Montminy LC Cantley 2005 The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin Science (New York, NY) 310 5754 1642 1646
9. M Zakikhani R Dowling IG Fantus N Sonenberg M Pollak 2006 Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells Cancer Res 66 21 10269 10273
10. SL Bowker SR Majumdar P Veugelers JA Johnson 2006 Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin Diabetes care 29 2 254 258
11. JM Evans LA Donnelly AM Emslie-Smith DR Alessi AD Morris 2005 Metformin and reduced risk of cancer in diabetic patients BMJ Clin Res Ed 330 7503 1304 1305
12. JD Lalau C Lacroix P Compagnon B de Cagny JP Rigaud G Bleichner P Chauveau P Dulbecco C Guerin JM Haegy 1995 Role of metformin accumulation in metformin-associated lactic acidosis Diabetes Care 18 6 779 784
13. K Hamada T Sasaki PA Koni M Natsui H Kishimoto J Sasaki N Yajima Y Horie G Hasegawa M Naito J Miyazaki T Suda H Itoh K Nakao TW Mak T Nakano A Suzuki 2005 The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis Genes Dev 19 17 2054 2065
14. C Blancher JW Moore N Robertson AL Harris 2001 Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway Cancer Res 61 19 7349 7355
15. S Wen J Stolarov MP Myers JD Su MH Wigler NK Tonks DL Durden 2001 PTEN controls tumor-induced angiogenesis Proc Natl Acad Sci USA 98 8 4622 4627
16. VN Anisimov LM Berstein PA Egormin TS Piskunova IG Popovich MA Zabezhinski IG Kovalenko TE Poroshina AV Semenchenko M Provinciali F Re C Franceschi 2005 Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice Exp Gerontol 40 8-9 685 693